Literature DB >> 6668314

High-performance liquid chromatographic quantitation of trimethoprim, sulfamethoxazole, and N4-acetylsulfamethoxazole in body fluids.

A Weber, K E Opheim, G R Siber, J F Ericson, A L Smith.   

Abstract

We describe a rapid, precise and simple procedure for the quantitative determination of trimethoprim, sulfamethoxazole, and N4-acetylsulfamethoxazole in body fluids by reversed-phase high-performance liquid chromatography. This method utilizes antipyrine as an internal standard with the compounds detected by dual-wavelength monitoring at 225 nm and 254 nm after a single-step extraction. Precision, sensitivity, and accuracy of this assay are within the range of clinical utility; the coefficient of variation is less than or equal to 3%, sensitivity less than 0.5 micrograms/ml for all compounds, and recovery greater than 97%. The short time for performance and small sample size makes the assay ideal for clinical drug monitoring and pharmacokinetic studies.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6668314     DOI: 10.1016/s0378-4347(00)84793-3

Source DB:  PubMed          Journal:  J Chromatogr


  7 in total

1.  Development and validation of an HPLC method for simultaneous determination of trimethoprim and sulfamethoxazole in human plasma.

Authors:  Esin Sayar; Selma Sahin; Semsettin Cevheroglu; A Atilla Hincal
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2010-09       Impact factor: 2.441

2.  Pharmacodynamic evaluation of ofloxacin and trimethoprim-sulfamethoxazole in vaginal fluid of women treated for acute cystitis.

Authors:  T A Tartaglione; C R Johnson; P Brust; K Opheim; T M Hooton; W E Stamm
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

3.  Voltammetric sensing of sulfamethoxazole using a glassy carbon electrode modified with a graphitic carbon nitride and zinc oxide nanocomposite.

Authors:  Paramasivam Balasubramanian; Ramki Settu; Shen-Ming Chen; Tse-Wei Chen
Journal:  Mikrochim Acta       Date:  2018-07-31       Impact factor: 5.833

4.  Radioenzymatic assay for trimethoprim in very small serum samples.

Authors:  R Yogev; C Melick; L Tan-Pong
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

Review 5.  Clinical pharmacokinetics of enzyme inhibitors in antimicrobial chemotherapy.

Authors:  I D Watson; M J Stewart; D J Platt
Journal:  Clin Pharmacokinet       Date:  1988-09       Impact factor: 6.447

6.  Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients.

Authors:  T W Chin; A Vandenbroucke; I W Fong
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

7.  The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects.

Authors:  Mikko Niemi; Lauri I Kajosaari; Mikko Neuvonen; Janne T Backman; Pertti J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.